tetano
Editor, Senior Moderator
J Clin Virol
. 2022 Aug 19;155:105269.
doi: 10.1016/j.jcv.2022.105269. Online ahead of print.
Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays
Lars Müller[SUP] 1 [/SUP], Judith Kannenberg[SUP] 1 [/SUP], Ronald Biemann[SUP] 2 [/SUP], Mario Hönemann[SUP] 1 [/SUP], Grit Ackermann[SUP] 3 [/SUP], Christian Jassoy[SUP] 4 [/SUP]
Affiliations
Abstract
Background: The concentration of antibodies against the SARS-CoV-2 spike protein is frequently being measured for clinical and epidemiological purposes. The aim of this study was to examine whether the results of different quantitative SARS-CoV-2 spike antibody assays are comparable.
Material and methods: The Siemens SARS-CoV-2 IgG, Abbott SARS-CoV-2 IgG II Quant, Roche ElecsysT Anti-SARS-CoV-2 S, and Euroimmun Anti-SARS-CoV-2-QuantiVac assay were compared with 110 sera from patients 6-9 months after SARS-CoV-2 infection and the WHO First International SARS-CoV-2 antibody standard 20/136. The antibody values were converted into WHO binding antibody units (BAU)/ml. The diagnostic sensitivity of the assays was determined and the antibody values were compared.
Results: The diagnostic sensitivity ranged from 57.3% (Euroimmun) to 100% (Roche). The antibody concentration values of different assays correlated with Pearson coefficients of correlation between 0.729 and 0.953. The geometric mean antibody values of the Abbott, Siemens and Euroimmun assay varied by a factor of 1.1-1.2. The geometric mean antibody values of the Roche assay were 2.4-2.8 times higher than those from the other assays. The assays yielded varying results with the WHO International antibody standard.
Conclusions: The quantitative SARS-CoV-2 antibody assays from Abbott, Siemens, Roche and Euroimmun correlate strongly but differ in the antibody concentrations. Therefore, the same assay should be used when testing patients repeatedly. In addition, the name of the assay used and the manufacturer should be indicated along with the test results.
Keywords: Coronavirus disease 2019 (COVID-19); Quantitative SARS-CoV-2 antibody assay; SARS-CoV-2 spike protein; Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
. 2022 Aug 19;155:105269.
doi: 10.1016/j.jcv.2022.105269. Online ahead of print.
Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays
Lars Müller[SUP] 1 [/SUP], Judith Kannenberg[SUP] 1 [/SUP], Ronald Biemann[SUP] 2 [/SUP], Mario Hönemann[SUP] 1 [/SUP], Grit Ackermann[SUP] 3 [/SUP], Christian Jassoy[SUP] 4 [/SUP]
Affiliations
- PMID: 36029637
- DOI: 10.1016/j.jcv.2022.105269
Abstract
Background: The concentration of antibodies against the SARS-CoV-2 spike protein is frequently being measured for clinical and epidemiological purposes. The aim of this study was to examine whether the results of different quantitative SARS-CoV-2 spike antibody assays are comparable.
Material and methods: The Siemens SARS-CoV-2 IgG, Abbott SARS-CoV-2 IgG II Quant, Roche ElecsysT Anti-SARS-CoV-2 S, and Euroimmun Anti-SARS-CoV-2-QuantiVac assay were compared with 110 sera from patients 6-9 months after SARS-CoV-2 infection and the WHO First International SARS-CoV-2 antibody standard 20/136. The antibody values were converted into WHO binding antibody units (BAU)/ml. The diagnostic sensitivity of the assays was determined and the antibody values were compared.
Results: The diagnostic sensitivity ranged from 57.3% (Euroimmun) to 100% (Roche). The antibody concentration values of different assays correlated with Pearson coefficients of correlation between 0.729 and 0.953. The geometric mean antibody values of the Abbott, Siemens and Euroimmun assay varied by a factor of 1.1-1.2. The geometric mean antibody values of the Roche assay were 2.4-2.8 times higher than those from the other assays. The assays yielded varying results with the WHO International antibody standard.
Conclusions: The quantitative SARS-CoV-2 antibody assays from Abbott, Siemens, Roche and Euroimmun correlate strongly but differ in the antibody concentrations. Therefore, the same assay should be used when testing patients repeatedly. In addition, the name of the assay used and the manufacturer should be indicated along with the test results.
Keywords: Coronavirus disease 2019 (COVID-19); Quantitative SARS-CoV-2 antibody assay; SARS-CoV-2 spike protein; Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).